Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Conquer Paralysis Now (CPN) is a leading non-profit organization dedicated to finding a cure for paralysis resulting from spinal cord injuries (SCI). Founded by former IndyCar driver Sam Schmidt, the foundation operates on a dual mission: funding high-impact scientific research to restore function and providing state-of-the-art rehabilitation through its Driven NeuroRecovery Centers. CPN is notable for its 'CPN Challenge' program, which offers multi-million dollar prizes to incentivize global researchers to achieve functional recovery in chronic SCI patients. By fostering international collaboration and bridging the gap between laboratory discovery and clinical treatment, CPN aims to accelerate the delivery of curative therapies to the paralysis community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Conquer Paralysis Now.